+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Substance Abuse Treatment Market Research Report by Substance Abuse Type (Alcohol Addiction, Cocaine, and Marijuana), Product, Treatment Option, Distribution Channel, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 158 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5460294
UP TO OFF until Dec 31st 2022
The United States Substance Abuse Treatment Market size was estimated at USD 1,063.12 million in 2021, USD 1,150.26 million in 2022, and is projected to grow at a CAGR 9.30% to reach USD 1,812.92 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Substance Abuse Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Substance Abuse Type, the market was studied across Alcohol Addiction, Cocaine, Marijuana, and Nicotine Addiction.
  • Based on Product, the market was studied across Behavioral Treatment and Drugs. The Drugs is further studied across Acamprosate, Buprenorphine, Bupropion, Disulfiram, Methadone, Naltrexone, and Varenicline.
  • Based on Treatment Option, the market was studied across Group Counseling, In-patient Treatment, Individualized Drug Counseling, Long-Term Residential Treatment, Outpatient Treatment Programs, and Short-Term Residential Treatment.
  • Based on Distribution Channel, the market was studied across Hospital Pharmacies and Retail Pharmacies & Drug Stores.
  • Based on State, the market was studied across California, Florida, Illinois, Massachusetts, Michigan, New York, Ohio, Pennsylvania, Tennessee, Texas, and Wisconsin.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Substance Abuse Treatment market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Substance Abuse Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Substance Abuse Treatment Market, including Alkermes PLC, Amphastar Pharmaceuticals, Inc., BioCorRx Inc., Elite Pharmaceuticals, Inc., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Hikma Pharmaceuticals PLC, Indivior PLC, Lupin Limited, Mallinckrodt LLC, Novartis International AG, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Viatris Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Substance Abuse Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Substance Abuse Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Substance Abuse Treatment Market?
4. What is the competitive strategic window for opportunities in the United States Substance Abuse Treatment Market?
5. What are the technology trends and regulatory frameworks in the United States Substance Abuse Treatment Market?
6. What is the market share of the leading vendors in the United States Substance Abuse Treatment Market?
7. What modes and strategic moves are considered suitable for entering the United States Substance Abuse Treatment Market?
Frequently Asked Questions about the U.S. Substance Abuse Treatment Market

What is the estimated value of the U.S. Substance Abuse Treatment Market?

The U.S. Substance Abuse Treatment Market was estimated to be valued at $1063.12 Million in 2021.

What is the growth rate of the U.S. Substance Abuse Treatment Market?

The growth rate of the U.S. Substance Abuse Treatment Market is 9.3%, with an estimated value of $1812.92 Million by 2027.

What is the forecasted size of the U.S. Substance Abuse Treatment Market?

The U.S. Substance Abuse Treatment Market is estimated to be worth $1812.92 Million by 2027.

Who are the key companies in the U.S. Substance Abuse Treatment Market?

Key companies in the U.S. Substance Abuse Treatment Market include Alkermes PLC, Amphastar Pharmaceuticals, Inc., BioCorRx Inc., Elite Pharmaceuticals, Inc., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Hikma Pharmaceuticals PLC, Indivior PLC and Mallinckrodt LLC.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Surging Rate of Drug Addiction And the Growing Prevalence of Alcohol and Smoking Among U.S. Teenagers
5.1.1.2. Rising Patient Awareness through Significant Drug Awareness Campaigns and Prevention Programs in the U.S.
5.1.2. Restraints
5.1.2.1. Reluctance to Seek Treatment and the Discontinuation of Behavioral Therapies
5.1.3. Opportunities
5.1.3.1. Emerging Number of Treatment Centers among Private Recovery Facilities in the U.S.
5.1.3.2. Novel Treatment Development and Improving Insurance Coverage Scenario
5.1.4. Challenges
5.1.4.1. Relatively High Cost of the Treatments and Limited Reimbursement Policy
5.2. Cumulative Impact of COVID-19
6. Substance Abuse Treatment Market, by Substance Abuse Type
6.1. Introduction
6.2. Alcohol Addiction
6.3. Cocaine
6.4. Marijuana
6.5. Nicotine Addiction
7. Substance Abuse Treatment Market, by Product
7.1. Introduction
7.2. Behavioral Treatment
7.3. Drugs
7.3.1. Acamprosate
7.3.2. Buprenorphine
7.3.3. Bupropion
7.3.4. Disulfiram
7.3.5. Methadone
7.3.6. Naltrexone
7.3.7. Varenicline
8. Substance Abuse Treatment Market, by Treatment Option
8.1. Introduction
8.2. Group Counseling
8.3. In-patient Treatment
8.4. Individualized Drug Counseling
8.5. Long-Term Residential Treatment
8.6. Outpatient Treatment Programs
8.7. Short-Term Residential Treatment
9. Substance Abuse Treatment Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Retail Pharmacies & Drug Stores
10. California Substance Abuse Treatment Market11. Florida Substance Abuse Treatment Market12. Illinois Substance Abuse Treatment Market13. Massachusetts Substance Abuse Treatment Market14. Michigan Substance Abuse Treatment Market15. New York Substance Abuse Treatment Market16. Ohio Substance Abuse Treatment Market17. Pennsylvania Substance Abuse Treatment Market18. Tennessee Substance Abuse Treatment Market19. Texas Substance Abuse Treatment Market20. Wisconsin Substance Abuse Treatment Market
21. Competitive Landscape
21.1. FPNV Positioning Matrix
21.1.1. Quadrants
21.1.2. Business Strategy
21.1.3. Product Satisfaction
21.2. Market Ranking Analysis
21.3. Market Share Analysis, By Key Player
21.4. Competitive Scenario
21.4.1. Merger & Acquisition
21.4.2. Agreement, Collaboration, & Partnership
21.4.3. New Product Launch & Enhancement
21.4.4. Investment & Funding
21.4.5. Award, Recognition, & Expansion
22. Company Usability Profiles
22.1. Alkermes PLC
22.2. Amphastar Pharmaceuticals, Inc.
22.3. BioCorRx Inc.
22.4. Elite Pharmaceuticals, Inc.
22.5. GlaxoSmithKline PLC
22.6. Glenmark Pharmaceuticals Limited
22.7. Hikma Pharmaceuticals PLC
22.8. Indivior PLC
22.9. Lupin Limited
22.10. Mallinckrodt LLC
22.11. Novartis International AG
22.12. Pfizer Inc.
22.13. Purdue Pharma L.P.
22.14. Sanofi S.A.
22.15. Teva Pharmaceutical Industries Ltd.
22.16. Viatris Inc.
23. Appendix
23.1. Discussion Guide
23.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET DYNAMICS
FIGURE 8. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2027
FIGURE 11. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ALCOHOL ADDICTION, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ALCOHOL ADDICTION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COCAINE, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COCAINE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY MARIJUANA, 2019-2027 (USD MILLION)
FIGURE 16. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY MARIJUANA, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY NICOTINE ADDICTION, 2019-2027 (USD MILLION)
FIGURE 18. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY NICOTINE ADDICTION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 20. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2027
FIGURE 22. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY BEHAVIORAL TREATMENT, 2019-2027 (USD MILLION)
FIGURE 23. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY BEHAVIORAL TREATMENT, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 24. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, 2019-2027 (USD MILLION)
FIGURE 25. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 26. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ACAMPROSATE, 2019-2027 (USD MILLION)
FIGURE 27. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ACAMPROSATE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 28. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY BUPRENORPHINE, 2019-2027 (USD MILLION)
FIGURE 29. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY BUPRENORPHINE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 30. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY BUPROPION, 2019-2027 (USD MILLION)
FIGURE 31. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY BUPROPION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 32. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISULFIRAM, 2019-2027 (USD MILLION)
FIGURE 33. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISULFIRAM, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 34. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY METHADONE, 2019-2027 (USD MILLION)
FIGURE 35. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY METHADONE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 36. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY NALTREXONE, 2019-2027 (USD MILLION)
FIGURE 37. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY NALTREXONE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 38. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY VARENICLINE, 2019-2027 (USD MILLION)
FIGURE 39. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY VARENICLINE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 40. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2021 VS 2027 (%)
FIGURE 41. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2021 VS 2027 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2027
FIGURE 43. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY GROUP COUNSELING, 2019-2027 (USD MILLION)
FIGURE 44. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY GROUP COUNSELING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 45. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY IN-PATIENT TREATMENT, 2019-2027 (USD MILLION)
FIGURE 46. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY IN-PATIENT TREATMENT, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 47. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INDIVIDUALIZED DRUG COUNSELING, 2019-2027 (USD MILLION)
FIGURE 48. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INDIVIDUALIZED DRUG COUNSELING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 49. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY LONG-TERM RESIDENTIAL TREATMENT, 2019-2027 (USD MILLION)
FIGURE 50. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY LONG-TERM RESIDENTIAL TREATMENT, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 51. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT TREATMENT PROGRAMS, 2019-2027 (USD MILLION)
FIGURE 52. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT TREATMENT PROGRAMS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 53. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SHORT-TERM RESIDENTIAL TREATMENT, 2019-2027 (USD MILLION)
FIGURE 54. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SHORT-TERM RESIDENTIAL TREATMENT, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 55. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 56. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD MILLION)
FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 58. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 59. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 60. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, 2019-2027 (USD MILLION)
FIGURE 61. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 62. CALIFORNIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. FLORIDA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. ILLINOIS SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. MASSACHUSETTS SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. MICHIGAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. NEW YORK SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. OHIO SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. PENNSYLVANIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. TENNESSEE SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. TEXAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. WISCONSIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 74. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 75. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ALCOHOL ADDICTION, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COCAINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY MARIJUANA, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY NICOTINE ADDICTION, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY BEHAVIORAL TREATMENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUGS, BY STATE, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ACAMPROSATE, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY BUPRENORPHINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY BUPROPION, BY STATE, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISULFIRAM, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY METHADONE, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY NALTREXONE, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY VARENICLINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 20. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY GROUP COUNSELING, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY IN-PATIENT TREATMENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INDIVIDUALIZED DRUG COUNSELING, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY LONG-TERM RESIDENTIAL TREATMENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT TREATMENT PROGRAMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 26. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SHORT-TERM RESIDENTIAL TREATMENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY STATE, 2019-2027 (USD MILLION)
TABLE 30. CALIFORNIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 31. CALIFORNIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2019-2027 (USD MILLION)
TABLE 32. CALIFORNIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 33. CALIFORNIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2019-2027 (USD MILLION)
TABLE 34. CALIFORNIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 35. FLORIDA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 36. FLORIDA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2019-2027 (USD MILLION)
TABLE 37. FLORIDA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 38. FLORIDA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2019-2027 (USD MILLION)
TABLE 39. FLORIDA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 40. ILLINOIS SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 41. ILLINOIS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2019-2027 (USD MILLION)
TABLE 42. ILLINOIS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 43. ILLINOIS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2019-2027 (USD MILLION)
TABLE 44. ILLINOIS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 45. MASSACHUSETTS SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 46. MASSACHUSETTS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2019-2027 (USD MILLION)
TABLE 47. MASSACHUSETTS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 48. MASSACHUSETTS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2019-2027 (USD MILLION)
TABLE 49. MASSACHUSETTS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 50. MICHIGAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 51. MICHIGAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2019-2027 (USD MILLION)
TABLE 52. MICHIGAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 53. MICHIGAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2019-2027 (USD MILLION)
TABLE 54. MICHIGAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 55. NEW YORK SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 56. NEW YORK SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2019-2027 (USD MILLION)
TABLE 57. NEW YORK SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 58. NEW YORK SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2019-2027 (USD MILLION)
TABLE 59. NEW YORK SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 60. OHIO SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 61. OHIO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2019-2027 (USD MILLION)
TABLE 62. OHIO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 63. OHIO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2019-2027 (USD MILLION)
TABLE 64. OHIO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 65. PENNSYLVANIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 66. PENNSYLVANIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2019-2027 (USD MILLION)
TABLE 67. PENNSYLVANIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 68. PENNSYLVANIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2019-2027 (USD MILLION)
TABLE 69. PENNSYLVANIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 70. TENNESSEE SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 71. TENNESSEE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2019-2027 (USD MILLION)
TABLE 72. TENNESSEE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 73. TENNESSEE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2019-2027 (USD MILLION)
TABLE 74. TENNESSEE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 75. TEXAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 76. TEXAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2019-2027 (USD MILLION)
TABLE 77. TEXAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 78. TEXAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2019-2027 (USD MILLION)
TABLE 79. TEXAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 80. WISCONSIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 81. WISCONSIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2019-2027 (USD MILLION)
TABLE 82. WISCONSIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 83. WISCONSIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2019-2027 (USD MILLION)
TABLE 84. WISCONSIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 85. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 86. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 87. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 88. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET RANKING
TABLE 89. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
TABLE 90. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET MERGER & ACQUISITION
TABLE 91. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 92. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 93. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET INVESTMENT & FUNDING
TABLE 94. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 95. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET: LICENSE & PRICING

Companies Mentioned

  • Alkermes PLC
  • Amphastar Pharmaceuticals, Inc.
  • BioCorRx Inc.
  • Elite Pharmaceuticals, Inc.
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Hikma Pharmaceuticals PLC
  • Indivior PLC
  • Lupin Limited
  • Mallinckrodt LLC
  • Novartis International AG
  • Pfizer Inc.
  • Purdue Pharma L.P.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Methodology

Loading
LOADING...